Search results for "keratosis"

showing 10 items of 60 documents

Physician–patient communication and patient-reported outcomes in the actinic keratosis treatment adherence initiative (AK-TRAIN): a multicenter, pros…

2017

Background: Patients with multiple actinic keratoses (AKs) should be treated with field-directed therapy. Such treatments challenge patients’ adherence due to out-of-pocket costs, length of treatment and severity of local skin reactions (LSRs). Effective physician–patient communication (PPC) may buffer therapy-related distress, thus improving quality of life, treatment satisfaction and adherence. Objectives: We evaluated the interplay between PPC, LSR intensity (safety) and lesion clearance rates (effectiveness) on treatment satisfaction, quality of life and treatment adherence among patients with multiple AKs receiving topical field-directed therapies. Methods: In this observational, multi…

Male2708; infectious diseases; actinic keratosesDiclofenacActinictopical field‐directed therapyAnti-Inflammatory AgentsAntineoplastic AgentsAdministration CutaneousMedication AdherenceAdministration Cutaneous; Aged; Aged 80 and over; Anti-Inflammatory Agents Non-Steroidal; Antineoplastic Agents; Diclofenac; Diterpenes; Drug Eruptions; Female; Humans; Imiquimod; Italy; Keratosis Actinic; Longitudinal Studies; Male; Middle Aged; Patient Reported Outcome Measures; Prospective Studies; Quality of Life; Communication; Medication Adherence; Patient Satisfaction; Physician-Patient Relationsactinic keratoses2708; Infectious Diseases80 and overHumansLongitudinal StudiesPatient Reported Outcome MeasuresProspective Studiesactinic keratoseAgedAged 80 and overPhysician-Patient RelationsImiquimodtreatmentCommunicationAnti-Inflammatory Agents Non-SteroidalKeratosisMiddle AgedKeratosis ActinicInfectious DiseasesCutaneousItalyPatient SatisfactionAdministrationQuality of LifeFemaleDrug EruptionsDiterpenesSettore MED/35 - MALATTIE CUTANEE E VENEREENon-Steroidal2708
researchProduct

Evaluation of cell proliferation rate in non-dysplastic leukoplakias

2008

Objective: Analyze whether the most frequent cases of non-dysplastic leukoplakias, hyperkeratosis (H), acanthosis (A), and hyperkeratosis with acanthosis (HA) have similar cell proliferation rates and to compare them with epithelial dysplastic (ED) leukoplakias and normal oral epithelium (NOE).Study design: The sample comprised 10 cases of normal oral epithelium, 10 cases of hyperkeratosis, 10 cases of acanthosis, 10 cases of hyperkeratosis with acanthosis and 10 cases of epithelial dysplasia. The mean number of AgNORs per nucleus (mAgNOR) and the mean percentage of cells with 1, 2, 3 and 4 or more AgNORs per nucleus (pAgNOR) were recorded. Results: The results of mAgNOR showed differences …

MaleEpithelial dysplasiaPathologymedicine.medical_specialtyHyperkeratosisAcanthosisHyperkeratosisEpithelial dysplasiaAcanthosisBasal (phylogenetics)Biological profileProliferation rateOral and maxillofacial pathologyHumansMedicineLeucoplasia bucalGeneral DentistryCell proliferationCell ProliferationLeukoplakiabusiness.industryAntigens NuclearProliferação celularMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Doencas [Mucosa bucal]AgNORstomatognathic diseasesOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASPatologia bucalFemaleSurgeryLeukoplakia OralbusinessLeukoplakia
researchProduct

Key features and clinical variability of COG6-CDG

2015

The conserved oligomeric Golgi (COG) complex consists of eight subunits and plays a crucial role in Golgi trafficking and positioning of glycosylation enzymes. Mutations in all COG subunits, except subunit 3, have been detected in patients with congenital disorders of glycosylation (CDG) of variable severity. So far, 3 families with a total of 10 individuals with biallelic COG6 mutations have been described, showing a broad clinical spectrum. Here we present 7 additional patients with 4 novel COG6 mutations. In spite of clinical variability, we delineate the core features of COG6-CDG i.e. liver involvement (9/10), microcephaly (8/10), developmental disability (8/10), recurrent infections (7…

MaleMicrocephalyGlycosylationAdolescentEndocrinology Diabetes and MetabolismProtein subunitHyperkeratosisMolecular Sequence DataGolgi ApparatusCase ReportsResearch SupportBiochemistryConserved oligomeric Golgi complexYoung AdultEndocrinologyCogCongenital Disorders of GlycosylationGeneticsJournal ArticleMedicineHumansNon-U.S. Gov'tChildMolecular BiologyExome sequencingGenetic Association StudiesGeneticsbusiness.industryConserved oligomeric Golgi complexResearch Support Non-U.S. Gov'tHigh-Throughput Nucleotide SequencingInfantCongenital disorder of glycosylationmedicine.diseasePhenotypeAdaptor Proteins Vesicular TransportPhenotypeCOG6MutationMicrocephalyFemaleCDGbusinessCongenital disorder of glycosylation
researchProduct

Visualization of Keratin with Diffuse Reflectance and Autofluorescence Imaging and Nonlinear Optical Microscopy in a Rare Keratinopathic Ichthyosis.

2021

Keratins are one of the main fluorophores of the skin. Keratinization disorders can lead to alterations in the optical properties of the skin. We set out to investigate a rare form of keratinopathic ichthyosis caused by KRT1 mutation with two different optical imaging methods. We used a newly developed light emitting diode (LED) based device to analyze autofluorescence signal at 405 nm excitation and diffuse reflectance at 526 nm in vivo. Mean autofluorescence intensity of the hyperkeratotic palmar skin was markedly higher in comparison to the healthy control (162.35 vs. 51.14). To further assess the skin status, we examined samples from affected skin areas ex vivo by nonlinear optical micr…

MaleNonlinear Optical MicroscopyHyperkeratosisautofluorescencelcsh:Chemical technologyBiochemistryAnalytical Chemistry030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineIn vivoKeratinmedicineHumanslcsh:TP1-1185Electrical and Electronic EngineeringInstrumentationkeratinSkinchemistry.chemical_classificationHyperkeratosis Epidermolyticintegumentary systemhyperkeratosisChemistryCommunicationOptical ImagingLEDnonlinear microscopyepidermolytic ichthyosismedicine.diseasediffuse reflectanceFluorescenceNonlinear optical microscopyAtomic and Molecular Physics and OpticsAutofluorescencemedicine.anatomical_structure030220 oncology & carcinogenesisChild Preschoolmultiphoton microscopyhistopathologyKeratinsKRT1EpidermisDiffuse reflectionBiomedical engineeringSensors (Basel, Switzerland)
researchProduct

Determination of cytokeratins 1, 13 and 14 in oral lichen planus

2014

Cytokeratins (CK) are molecules of the cytoskeleton that contribute to the cellular differenciation. We studied the expression of CK1, CK13 and CK14 in thirty-three patients with OLP. The biopsied lesions were located in the dorsal surface of the tongue, the palatal keratinized mucosa and the nonkeratinized buccal mucosa. Objectives: This study aimed to determine the expression of CK1, CK13 and CK14 in oral lichen planus (OLP) and its relations with: clinical patterns, prognosis, drugs and tobacco intake and histopathological features. Study Design: Immunohistochemical analysis, retrospective, descriptive, observational and no randomized study. Results: No significant difference was observe…

MalePathologyMedicina ClínicaBasal (phylogenetics)//purl.org/becyt/ford/3.2 [https]Aged 80 and overMiddle Aged:CIENCIAS MÉDICAS [UNESCO]ImmunohistochemistryCiencias de la saludmedicine.anatomical_structureUNESCO::CIENCIAS MÉDICASORAL LICHEN PLANUS//purl.org/becyt/ford/3 [https]FemaleAdultmedicine.medical_specialtyCIENCIAS MÉDICAS Y DE LA SALUDCK1CYTOKERATINOdontologíaBASAL CELL VACUOLIZATIONOdontología Medicina y Cirugía OralCytokeratinstomatognathic systemTongueOral and maxillofacial pathologymedicineHumansGeneral DentistryAgedRetrospective StudiesCK13Oral Medicine and Pathologybusiness.industryCK14ResearchKeratin-13Keratin-14medicine.diseaseOrthokeratosisEpitheliumLYMPHOCYTIC EXOCYTOSISstomatognathic diseasesOtorhinolaryngologyVacuolizationSurgeryOral lichen planusbusinessKeratin-1Lichen Planus Oral
researchProduct

Pathogenesis of Paraneoplastic Follicular Hyperkeratotic Spicules in Multiple Myeloma

1990

• We describe a 62-year-old man with multiple myeloma who developed horny spicules on his face, particularly on his nose. IgG-λ monoclonal gammopathy was detected, and the serum dysprotein was shown to be a cryoglobulin, which forms a cryogel at low temperatures. Light and electron microscopic and immunohistochemical examinations showed an intercellular precipitation and massive accumulation of the IgG dysprotein and cryoglobulin between the keratinocytes of the upper epidermis and the infundibular epithelium. The follicles were dilated and filled with parakeratotic cells, the protein deposits between them and a rudimentary hair thus resulting in the clinically visible symptoms of horny spi…

MalePathologymedicine.medical_specialtyFluorescent Antibody TechniqueDermatologyBiologyPathogenesisCryoglobulinImmunoglobulin lambda-ChainsHypergammaglobulinemiamedicineHumansMultiple myelomaEpidermis (botany)KeratosisGeneral MedicineMiddle Agedmedicine.diseaseImmunohistochemistryCryoglobulinemiaEpitheliumMicroscopy Electronmedicine.anatomical_structureCryoglobulinemiaImmunoglobulin GImmunohistochemistryBody regionMultiple MyelomaFacial DermatosesHairArchives of Dermatology
researchProduct

Atypical facial porokeratosis of Mibelli

1991

Summary An atypical case of porokeratosis of Mibelli that was localized to the face is reported.

MalePathologymedicine.medical_specialtyKeratosisRespiratory tract infectionsbusiness.industryKeratosisDermatologyMiddle Agedmedicine.diseaseFaceHumansMedicinebusinessRespiratory Tract InfectionsSkinPorokeratosisBritish Journal of Dermatology
researchProduct

Familial seborrhoeic keratosis associated with multiple 'pure reticulated acanthomas' and infundibulocystic basal cell carcinomas.

2017

Background A variety of genodermatoses with multiple cutaneous tumors with germline genetic alterations such as Gorlin syndrome with PTCH1 gene mutations have been described. Other cutaneous syndromes have been associated with somatic gene mutations, such as FGFR3 in familial seborrhoeic keratosis. Objective We describe the clinical, dermoscopic, and histopathological features of multiple cutaneous lesions, mostly infundibulocystic basal cell carcinomas and pure reticulated acanthomas, present in a family affected by familial seborrhoeic keratosis. In addition, we tested for possible germline alterations in the FGFR3 and PTCH1 genes. Methods Ten members of one family were clinically examine…

MalePathologymedicine.medical_specialtySkin NeoplasmsKeratosisDermoscopyDermatologyGene mutationBiologyGermline030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinemedicineHumansReceptor Fibroblast Growth Factor Type 3Keratosis SeborrheicGerm-Line MutationAgedPolymorphism Geneticmedicine.diagnostic_testApocrinePTCH1 GeneMiddle Agedmedicine.diseaseDermatologyPedigreePatched-1 ReceptorPTCH1Carcinoma Basal Cell030220 oncology & carcinogenesisAcanthomaSkin biopsyFemaleAcanthoma
researchProduct

A randomized, intraindividual, non-inferiority, Phase III study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the tre…

2018

Abstract Background The most effective treatment modality for actinic keratosis (AK) is photodynamic therapy (PDT). Major obstacles of PDT are the need of a special illumination device and pain accompanying the illumination. These issues may be overcome by replacing an artificial high‐power light source with natural daylight for more extended illumination at lower light doses. Objective To determine whether BF‐200 ALA (a nanoemulsion gel containing 7.8% 5‐aminolaevulinic acid) is non‐inferior to MAL (a cream containing 16% methyl‐aminolaevulinate) in the treatment of mild‐to‐moderate AK with daylight PDT (dPDT). Non‐inferiority of the primary efficacy variable (total lesion clearance rate p…

Malemedicine.medical_specialtyKeratosisgenetic structuresOriginal Articles and Short Reports Oncologymedicine.medical_treatmentUrologySkin CreamPhotodynamic therapyDermatologyAdministration CutaneousSeverity of Illness IndexStatistics Nonparametriclaw.inventionLesion030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineRandomized controlled triallawGermanySeverity of illnessmedicineClinical endpointHumansAgedPhotosensitizing Agentsbusiness.industryActinic keratosisAminolevulinic Acidmedicine.diseasePrognosisClinical trialKeratosis ActinicInfectious DiseasesTreatment OutcomePhotochemotherapySpain030220 oncology & carcinogenesisFemaleOriginal Articlemedicine.symptombusinessGelsJournal of the European Academy of Dermatology and Venereology : JEADV
researchProduct

A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminol…

2018

Background: Basal cell carcinoma (BCC) represents the most common nonmelanoma skin cancer worldwide, affecting mainly adult, fair-skinned individuals. The World Health Organization distinguishes aggressive and nonaggressive forms, of which prototypical variants of the latter are primary nodular and superficial BCC. Objective: To demonstrate noninferiority of BF-200 ALA (a nanoemulsion gel containing 5-aminolaevulinic acid) compared with MAL (a cream containing methyl aminolaevulinate) in the treatment of nonaggressive BCC with photodynamic therapy (PDT). Noninferiority of the primary efficacy variable (overall patient complete response 12 weeks after last PDT) would be declared if the mean …

Malemedicine.medical_specialtySkin Neoplasmsmedicine.medical_treatmentSkin CreamPhotodynamic therapyDermatologyAdministration Cutaneouslaw.invention030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineRandomized controlled trialMethyl aminolevulinatelawCarcinomaHumansMedicineBasal cell carcinomaAgedSkinPhotosensitizing Agentsbusiness.industryActinic keratosisAminolevulinic AcidMiddle Agedmedicine.diseaseDermatologyClinical trialTreatment OutcomePhotochemotherapyCarcinoma Basal Cell030220 oncology & carcinogenesisFemaleSkin cancerbusinessmedicine.drugBritish Journal of Dermatology
researchProduct